230615-47-1 Usage
Uses
Used in Pharmaceutical Industry:
1,4-Methanonaphthalene-2,3-diol, 1,2,3,4-tetrahydrois used as a key intermediate in the synthesis of various pharmaceuticals due to its ability to serve as a building block for the creation of new drugs. Its redox-active nature and potential health benefits, such as antioxidant and anti-inflammatory properties, make it a valuable component in drug development for treating a range of diseases.
Used in Materials Science:
In the field of materials science, 1,4-Methanonaphthalene-2,3-diol, 1,2,3,4-tetrahydrois utilized for its potential applications in developing new materials with unique properties. Its chemical structure and redox activity contribute to the advancement of material technologies.
Used as a Colorant:
1,4-Methanonaphthalene-2,3-diol, 1,2,3,4-tetrahydrois also used as a colorant in various products. Its chemical stability and color imparting capabilities make it suitable for use in industries that require coloring agents, such as cosmetics, textiles, and paints.
Check Digit Verification of cas no
The CAS Registry Mumber 230615-47-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,3,0,6,1 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 230615-47:
(8*2)+(7*3)+(6*0)+(5*6)+(4*1)+(3*5)+(2*4)+(1*7)=101
101 % 10 = 1
So 230615-47-1 is a valid CAS Registry Number.
230615-47-1Relevant articles and documents
ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
-
Paragraph 0446-0447, (2022/01/07)
An organometallic compound represented by Formula 1 and an organic light-emitting device including the same. The substituents of Formula 1 are the same as described in the specification.
PROCESSES FOR THE PREPARATION OF VARENICLINE AND INTERMEDIATES THEREOF
-
Page/Page column 8, (2009/12/28)
The invention provides an improved process for the preparation and purification of Varenicline and intermediates for the preparation of Varenicline.
Aryl fused azapolycyclic compounds
-
, (2008/06/13)
Compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, and R3are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; a
Aryl fused azapolycyclic compounds
-
, (2008/06/13)
Compounds of the formula and their pharmaceutically acceptable salts, wherein R1, R2, R3 and n are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.
